Metraipolis › archive › dc_c46d4a3ec952

Adaptimmune — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Adaptimmune
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-07T13:27:15.342Z
SHA-256 of the archived text
9a5e60adc99412b5b62085b2d626e34f23bbf0f5d0183fe5ab096de2e661f483
Stable URL of this page
https://metraipolis.com/documento/dc_c46d4a3ec952

How to cite

Adaptimmune — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Adaptimmune (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_c46d4a3ec952 (Metraipolis archive dc_c46d4a3ec952, sha256 9a5e60adc99412b5b62085b2d626e34f23bbf0f5d0183fe5ab096de2e661f483)
BibTeX
@misc{dcc46d4a3ec952,
  title = {Adaptimmune — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Adaptimmune},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_c46d4a3ec952; sha256 9a5e60adc99412b5b62085b2d626e34f23bbf0f5d0183fe5ab096de2e661f483},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Adaptimmune. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Adaptimmune is a biopharmaceutical company that develops T cell therapies against cancer. The company was founded in 2008 in the UK with links to both Oxford University and the University of Pennsylvania. It has headquarters in Philadelphia and Milton Park. In August 2024, the US Food and Drug Administration granted accelerated approval to Adaptimmune's Tecelra, a therapy against a rare form of cancer. Tecelra is the first T cell therapy to be approved for use against a solid tumor. In January 2025, the FDA granted breakthrough therapy designation to Adaptimmune's Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS). In July 2025, Adaptimmune announced their entry into a Definitive Agreement for Sale of Tecelra, lete-cel, and the pre-clinical uza-cel to US WorldMeds for $55M.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Adaptimmune» — https://en.wikipedia.org/wiki/Adaptimmune
Wikidata Q107400388: «biopharmaceutical company» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q107400388
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Adaptimmune?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1334040919, consultata il 2026-11-07T13:23:03.064Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 2ebd7d121089ed04dcc072d82daedd0b124422645cb93ebf56ccbd6c44c07c10